FDA authorizes Pfizer's COVID-19 vaccine for ages 12 to 15

A vial of Pfizer COVID-19 vaccine.
(Image credit: Getty Images)

The U.S. Food and Drug Administration on Monday authorized the use of the Pfizer-BioNTech COVID-19 vaccine for adolescents age 12 to 15.

Pfizer has said clinical trials show its COVID-19 vaccine to be 100 percent effective in this age group. The vaccine already has been approved for people age 16 and up.

The approval sets the stage for many middle schoolers and young high school students to be vaccinated before the next school year. However, the Centers for Disease Control and Prevention must also approve the authorization before vaccinations for the age group can begin.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us